Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

BUY
$1.19 - $2.19 $12,138 - $22,338
10,200 New
10,200 $15,000
Q2 2021

Aug 02, 2021

BUY
$4.26 - $6.5 $57,510 - $87,750
13,500 New
13,500 $59,000
Q2 2020

Aug 06, 2020

SELL
$4.78 - $8.26 $57,360 - $99,120
-12,000 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$4.0 - $21.53 $48,000 - $258,360
12,000 New
12,000 $48,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Sns Financial Group, LLC Portfolio

Follow Sns Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.